
CAS 953769-46-5
:Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
7 produits concernés.
4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-2-pyridinecarboxamide
CAS :Formule :C20H22N4O3SDegré de pureté :98%Couleur et forme :SolidMasse moléculaire :398.4787Ref: IN-DA00368U
1gÀ demander5gÀ demander1mg39,00€2mg49,00€5mg52,00€10mg66,00€25mg90,00€50mg120,00€100mg182,00€250mg213,00€500mg507,00€4-((2-(((1R,2R)-2-Hydroxycyclohexyl)Amino)Benzo[D]Thiazol-6-Yl)Oxy)-N-Methylpicolinamide
CAS :4-((2-(((1R,2R)-2-Hydroxycyclohexyl)Amino)Benzo[D]Thiazol-6-Yl)Oxy)-N-MethylpicolinamideDegré de pureté :98%Masse moléculaire :398.48g/molBLZ-945
CAS :Formule :C20H22N4O3SDegré de pureté :≥ 98.0%Couleur et forme :White to off-white powderMasse moléculaire :398.5Sotuletinib
CAS :Sotuletinib (BLZ945) is an orally active, effective and specific CSF-1R inhibitor, >1000-fold selective against its closest receptor tyrosine kinase homologs.Formule :C20H22N4O3SDegré de pureté :97.43% - 99.82%Couleur et forme :SolidMasse moléculaire :398.484-((2-(((1R,2R)-2-HYDROXYCYCLOHEXYL)AMINO)BENZO[D]THIAZOL-6-YL)OXY)-N-METHYLPICOLINAMIDE
CAS :Formule :C20H22N4O3SDegré de pureté :98%Masse moléculaire :398.48BLZ 945
CAS :<p>BLZ 945 is a novel small molecule that inhibits the activation of microglia, which are immune cells in the brain. It has been shown to inhibit tumor growth and radiation-induced tissue damage in cancer research. BLZ 945 also reduces the severity of autoimmune diseases by inhibiting the production of pro-inflammatory cytokines such as csf-1r and toll-like receptor 4. In addition, it has anti-inflammatory properties due to its inhibition of macrophage migration and adhesion. The drug has been shown to reduce the size of solid tumours in mice by reducing tumor angiogenesis and inhibiting cell proliferation.</p>Formule :C20H22N4O3SDegré de pureté :Min. 95%Masse moléculaire :398.48 g/mol





